Skip to main content

Prostate Artery Embolization

  • Chapter
  • First Online:
IR Playbook

Abstract

Benign prostatic hyperplasia (BPH) is exceedingly common in men over 50 years of age. It can range from asymptomatic to severely symptomatic with obstruction and recurrent urinary tract infections. For men with symptomatic BPH who do not respond to medical therapy, prostate artery embolization is a minimally invasive treatment option. Selective arterial embolization of the arteries supplying the prostate effectively reduces both the volume of the prostate and the associated symptoms. Additionally, prostate artery embolization can be used to treat hematuria of prostatic origin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Edwards JL. Diagnosis and management of benign prostatic hyperplasia. Am Fam Physician. 2008;77(10):1403–10.

    PubMed  Google Scholar 

  2. Carson C III, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology. 2003;61(4, Supplement 1):2–7. https://doi.org/10.1016/S0090-4295(03)00045-1.

    Article  PubMed  Google Scholar 

  3. Wilson JD, Roehrborn C. Long-term consequences of castration in men: lessons from the Skoptzy and the eunuchs of the Chinese and Ottoman courts. J Clin Endocrinol Metab. 1999;84(12):4324–31. https://doi.org/10.1210/jcem.84.12.6206.

    Article  PubMed  CAS  Google Scholar 

  4. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474–9.

    Article  PubMed  CAS  Google Scholar 

  5. Sarma AV, Wei JT. Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med. 2012;367(3):248–57. https://doi.org/10.1056/NEJMcp1106637.

    Article  PubMed  CAS  Google Scholar 

  6. Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev Urol. 2005;7(Suppl 9):S3–S14.

    PubMed  PubMed Central  Google Scholar 

  7. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44(6):637–49.

    Article  PubMed  Google Scholar 

  8. McNeal JE. The zonal anatomy of the prostate. Prostate. 1981;2(1):35–49. https://doi.org/10.1002/pros.2990020105.

    Article  PubMed  CAS  Google Scholar 

  9. Guneyli S, Ward E, Thomas S, Yousuf AN, Trilisky I, Peng Y, et al. Magnetic resonance imaging of benign prostatic hyperplasia. Diagn Interv Radiol. 2016;22(3):215–9.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Verma S, Rajesh A. A clinically relevant approach to imaging prostate cancer: review. Am J Roentgenol. 2011;196(3_supplement):S1–S10. https://doi.org/10.2214/AJR.09.7196.

    Article  Google Scholar 

  11. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524–48. https://doi.org/10.1001/jamaoncol.2016.5688.

    Article  PubMed  Google Scholar 

  12. Bischoff W, Goerttler U. Successful intra-arterial embolization of bleeding carcinoma of the prostate. UrologeAusg A. 1977;16(2):99–102.

    CAS  Google Scholar 

  13. Bilhim T, Pereira JA, Fernandes L, Tinto HR, Pisco JM. Angiographic anatomy of the male pelvic arteries. Am J Roentgenol. 2014;203(4):W373–82. https://doi.org/10.2214/AJR.13.11687.

    Article  Google Scholar 

  14. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793–803. https://doi.org/10.1016/j.juro.2011.01.074.

    Article  PubMed  Google Scholar 

  15. Moyer VA. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120. https://doi.org/10.7326/0003-4819-157-2-201207170-00459.

    Article  PubMed  Google Scholar 

  16. Bilhim T, Tinto HR, Fernandes L, Pisco JM. Radiological anatomy of prostatic arteries. Tech Vasc Interv Radiol. 2012;15(4):276–85. https://doi.org/10.1053/j.tvir.2012.09.006.

    Article  PubMed  Google Scholar 

  17. Yamaki K-I, Saga T, Doi Y, Aida K, Yoshizuka M. A statistical study of the branching of the human internal iliac artery. Kurume Med J. 1998;45(4):333–40. https://doi.org/10.2739/kurumemedj.45.333.

    Article  PubMed  CAS  Google Scholar 

  18. Golzarian J, Antunes AA, Bilhim T, Carnevale FC, Konety B, McVary KT, et al. Prostatic artery embolization to treat lower urinary tract symptoms related to benign prostatic hyperplasia and bleeding in patients with prostate cancer: proceedings from a Multidisciplinary Research Consensus Panel. J Vasc Interv Radiol. 2014;25(5):665–74. https://doi.org/10.1016/j.jvir.2013.11.003.

    Article  PubMed  Google Scholar 

  19. Loffroy R, Pottecher P, Cherblanc V, Favelier S, Estivalet L, Koutlidis N, et al. Current role of transcatheter arterial embolization for bladder and prostate hemorrhage. Diagn Interv Imaging. 2014;95(11):1027–34. https://doi.org/10.1016/j.diii.2014.03.008.

    Article  PubMed  CAS  Google Scholar 

  20. Lepor H. Medical treatment of benign prostatic hyperplasia. Rev Urol. 2011;13(1):20–33.

    PubMed  PubMed Central  Google Scholar 

  21. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349(25):2387–98. https://doi.org/10.1056/NEJMoa030656.

    Article  PubMed  CAS  Google Scholar 

  22. DeMeritt JS, Elmasri FF, Esposito MP, Rosenberg GS. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol. 2000;11(6):767–70. https://doi.org/10.1016/S1051-0443(07)61638-8.

    Article  PubMed  CAS  Google Scholar 

  23. Uflacker A, Haskal ZJ, Bilhim T, Patrie J, Huber T, Pisco JM. Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol. 2016;27(11):1686–1697.e8. https://doi.org/10.1016/j.jvir.2016.08.004.

    Article  PubMed  Google Scholar 

  24. Kuang M, Vu A, Athreya S. A meta-analysis of prostatic artery embolization in the treatment of symptomatic benign prostatic hyperplasia. J Vasc Interv Radiol. 2016;27(3):S53. https://doi.org/10.1016/j.jvir.2015.12.147.

    Article  Google Scholar 

  25. Cizman Z, Isaacson A, Burke C. Short- to midterm safety and efficacy of prostatic artery embolization: a systematic review. J Vasc Interv Radiol. 2016;27(10):1487–1493.e1. https://doi.org/10.1016/j.jvir.2016.04.015.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andre Uflacker .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Huber, T.C., Contrella, B.N., Uflacker, A. (2018). Prostate Artery Embolization. In: Keefe, N., Haskal, Z., Park, A., Angle, J. (eds) IR Playbook. Springer, Cham. https://doi.org/10.1007/978-3-319-71300-7_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-71300-7_29

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-71299-4

  • Online ISBN: 978-3-319-71300-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics